Inari Medical Inc (NARI) Stock Analysis

$79.970

+0.040 (+0.05%)At close

Loading chart…

High: 79.990
Open: 79.970
VWAP: 79.97
Vol: 2.36M
Mkt Cap: 2.73B
Low: 79.960
Amount: 188.66M
EV/EBITDA, TTM: 243.88

Inari Medical, Inc. is a medical device company. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss.

www.inarimedical.com

Valuation Metrics

The current forward P/E ratio for Inari Medical Inc (NARI) is 305.46, compared to its 5-year average forward P/E of 25.78.

Forward P/E

Fair

5Y Average P/E

25.78

Current P/E

305.46

Overvalued

483.03

Undervalued

-431.47

Forward EV/EBITDA

Fair

5Y Average EV/EBITDA

364.10

Current EV/EBITDA

243.88

Overvalued

1708.37

Undervalued

-980.16

Forward P/S

Fair

5Y Average P/S

7.59

Current P/S

6.60

Overvalued

10.51

Undervalued

4.66

Events Timeline

2025-02-19 (ET)

08:33:55

Stryker completes acquisition of Inari Medical

04:55:00

Kadant to replace Inari Medical in S&P 600 at open on 2/19

2025-02-13 (ET)

16:18:54

Kadant to replace Inari Medical in S&P 600 at open on 2/19

2025-01-17 (ET)

15:21:43

Stryker commences $80 per share cash offer for Inari Medical

2025-01-06 (ET)

15:09:39

Stryker to acquire Inari Medical for $80 per share in cash

Show More Events

News

NARI FAQ — answered by Alphio AI

Inari Medical, Inc. is a medical device company. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.